Please enable JavaScript to continue using this application.

Compare $ELDN vs $WHWK | Chartloom

Compare

$ELDN vs $WHWK

Eledon Pharmaceuticals Inc · Whitehawk Therapeutics Inc

ELDN

Eledon Pharmaceuticals Inc

WHWK

Whitehawk Therapeutics Inc

Compare $ELDN vs $WHWK

Comparing Eledon Pharmaceuticals Inc and Whitehawk Therapeutics Inc

ELDNEledon Pharmaceuticals Inc

WHWKWhitehawk Therapeutics Inc

ELDNEledon Pharmaceuticals Inc

Market cap

$191M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

53.1%

52W performance

-13.6%

FCF yield

-38.6%

WHWKWhitehawk Therapeutics Inc

Market cap

$189M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

44.3%

52W performance

65.3%

FCF yield

-36.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ELDN

WHWK

Detailed metrics comparison

ELDN

Eledon Pharmaceuticals Inc

WHWK

Whitehawk Therapeutics Inc

Market Cap

ELDN$191M

WHWK$189M

Enterprise Value

ELDN$185M

WHWK$104M

Price

ELDN$2.48

WHWK$3.52

P/E Ratio

ELDNN/A

WHWKN/A

P/S Ratio

ELDN0.00x

WHWK7.56x

EV/Sales

ELDN0.00x

WHWK0.00x

EV/EBITDA

ELDN0.00x

WHWK0.00x

P/B Ratio

ELDN2.81x

WHWK1.15x

P/FCF Ratio

ELDNN/A

WHWKN/A

EV/FCF

ELDN-2.50x

WHWK-1.50x

PEG Ratio

ELDNN/A

WHWKN/A

Forward P/E (NTM)

ELDNN/A

WHWKN/A

Forward P/S (NTM)

ELDNN/A

WHWKN/A

Revenue (TTM)

ELDN$0

WHWK$0

Revenue Growth (YoY)

ELDNN/A

WHWK-100.0%

Forward Rev Growth

ELDN325.8%

WHWK167.6%

Gross Margin (TTM)

ELDN0.0%

WHWK88.7%

Operating Margin (TTM)

ELDN0.0%

WHWK87.4%

EBITDA Margin (TTM)

ELDN0.0%

WHWK0.0%

Net Margin (TTM)

ELDN0.0%

WHWK99.4%

FCF Margin (TTM)

ELDNN/A

WHWKN/A

Net Income (TTM)

ELDN$-99M

WHWK$-80M

FCF (TTM)

ELDN$-74M

WHWK$-69M

EPS (TTM)

ELDN-$0.87

WHWK-$0.96

ROE (TTM)

ELDN-9848.0%

WHWK-5389.0%

ROA (TTM)

ELDN-6897.0%

WHWK-4997.0%

ROIC (TTM)

ELDN-9848.0%

WHWK-5389.0%

Cash

ELDN$7M

WHWK$85M

Debt

ELDN$0

WHWK$0

Net Cash/Debt

ELDN$7M

WHWK$85M

Current Ratio (TTM)

ELDN7.90x

WHWK17.38x

Quick Ratio (TTM)

ELDN7.60x

WHWK17.16x

Debt/Equity (TTM)

ELDN0.00x

WHWK0.00x

Debt/Assets (TTM)

ELDN0.0%

WHWK0.0%

Interest Coverage (TTM)

ELDNN/A

WHWKN/A

Net Debt/EBITDA (TTM)

ELDN0.00x

WHWK0.00x

Beta

ELDN1.01

WHWK0.99

52W Performance

ELDN-13.6%

WHWK65.3%

YTD Performance

ELDN53.1%

WHWK44.3%

% from 52W High

ELDN-46.1%

WHWK-35.9%

% from 52W Low

ELDN83.7%

WHWK88.2%

Asset Turnover (TTM)

ELDN0.00x

WHWK0.23x

FCF Yield (TTM)

ELDN-38.6%

WHWK-36.6%

Earnings Yield (TTM)

ELDN-51.5%

WHWK-42.2%

Dividend Yield (TTM)

ELDNN/A

WHWKN/A

Rule of 40

ELDN0.0

WHWK-100.0

EV/GP/RG

ELDNN/A

WHWKN/A

Ticker research

View ELDN research View WHWK research

Metric	ELDN Eledon Pharmaceuticals Inc	WHWK Whitehawk Therapeutics Inc
Market & Valuation
Market Cap	$191M	$189M
Enterprise Value	$185M	$104M
Price	$2.48	$3.52
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	7.56x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.81x	1.15x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.50x	-1.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	-100.0%
Forward Rev Growth	325.8%	167.6%
Profitability
Gross Margin (TTM)	0.0%	88.7%
Operating Margin (TTM)	0.0%	87.4%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	99.4%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-99M	$-80M
FCF (TTM)	$-74M	$-69M
EPS (TTM)	-$0.87	-$0.96
ROE (TTM)	-9848.0%	-5389.0%
ROA (TTM)	-6897.0%	-4997.0%
ROIC (TTM)	-9848.0%	-5389.0%
Financial Health
Cash	$7M	$85M
Debt	$0	$0
Net Cash/Debt	$7M	$85M
Current Ratio (TTM)	7.90x	17.38x
Quick Ratio (TTM)	7.60x	17.16x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.01	0.99
52W Performance	-13.6%	65.3%
YTD Performance	53.1%	44.3%
% from 52W High	-46.1%	-35.9%
% from 52W Low	83.7%	88.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.23x
FCF Yield (TTM)	-38.6%	-36.6%
Earnings Yield (TTM)	-51.5%	-42.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-100.0
EV/GP/RG	N/A	N/A
Ticker research	View ELDN research	View WHWK research

Valuation

P/S Ratio

ELDN

0.00x

WHWK

7.56x

EV/FCF

ELDN

-2.50x

WHWK

-1.50x

Growth & revenue

Revenue Growth TTM

WHWK

-100.0%

Forward Revenue Growth

ELDN

325.8%

WHWK

167.6%

Profitability & performance

Gross Margin

WHWK

88.7%

ELDN

0.0%

ROE

WHWK

-5389.0%

ELDN

-9848.0%

FCF Yield %

WHWK

-36.6%

ELDN

-38.6%

52-Week Performance

WHWK

65.3%

ELDN

-13.6%

Detailed metrics comparison

ELDN

Eledon Pharmaceuticals Inc

WHWK

Whitehawk Therapeutics Inc

Market Cap

ELDN$191M

WHWK$189M

Enterprise Value

ELDN$185M

WHWK$104M

Price

ELDN$2.48

WHWK$3.52

P/E Ratio

ELDNN/A

WHWKN/A

P/S Ratio

ELDN0.00x

WHWK7.56x

EV/Sales

ELDN0.00x

WHWK0.00x

EV/EBITDA

ELDN0.00x

WHWK0.00x

P/B Ratio

ELDN2.81x

WHWK1.15x

P/FCF Ratio

ELDNN/A

WHWKN/A

EV/FCF

ELDN-2.50x

WHWK-1.50x

PEG Ratio

ELDNN/A

WHWKN/A

Forward P/E (NTM)

ELDNN/A

WHWKN/A

Forward P/S (NTM)

ELDNN/A

WHWKN/A

Revenue (TTM)

ELDN$0

WHWK$0

Revenue Growth (YoY)

ELDNN/A

WHWK-100.0%

Forward Rev Growth

ELDN325.8%

WHWK167.6%

Gross Margin (TTM)

ELDN0.0%

WHWK88.7%

Operating Margin (TTM)

ELDN0.0%

WHWK87.4%

EBITDA Margin (TTM)

ELDN0.0%

WHWK0.0%

Net Margin (TTM)

ELDN0.0%

WHWK99.4%

FCF Margin (TTM)

ELDNN/A

WHWKN/A

Net Income (TTM)

ELDN$-99M

WHWK$-80M

FCF (TTM)

ELDN$-74M

WHWK$-69M

EPS (TTM)

ELDN-$0.87

WHWK-$0.96

ROE (TTM)

ELDN-9848.0%

WHWK-5389.0%

ROA (TTM)

ELDN-6897.0%

WHWK-4997.0%

ROIC (TTM)

ELDN-9848.0%

WHWK-5389.0%

Cash

ELDN$7M

WHWK$85M

Debt

ELDN$0

WHWK$0

Net Cash/Debt

ELDN$7M

WHWK$85M

Current Ratio (TTM)

ELDN7.90x

WHWK17.38x

Quick Ratio (TTM)

ELDN7.60x

WHWK17.16x

Debt/Equity (TTM)

ELDN0.00x

WHWK0.00x

Debt/Assets (TTM)

ELDN0.0%

WHWK0.0%

Interest Coverage (TTM)

ELDNN/A

WHWKN/A

Net Debt/EBITDA (TTM)

ELDN0.00x

WHWK0.00x

Beta

ELDN1.01

WHWK0.99

52W Performance

ELDN-13.6%

WHWK65.3%

YTD Performance

ELDN53.1%

WHWK44.3%

% from 52W High

ELDN-46.1%

WHWK-35.9%

% from 52W Low

ELDN83.7%

WHWK88.2%

Asset Turnover (TTM)

ELDN0.00x

WHWK0.23x

FCF Yield (TTM)

ELDN-38.6%

WHWK-36.6%

Earnings Yield (TTM)

ELDN-51.5%

WHWK-42.2%

Dividend Yield (TTM)

ELDNN/A

WHWKN/A

Rule of 40

ELDN0.0

WHWK-100.0

EV/GP/RG

ELDNN/A

WHWKN/A

Ticker research

View ELDN research View WHWK research

Metric	ELDN Eledon Pharmaceuticals Inc	WHWK Whitehawk Therapeutics Inc
Market & Valuation
Market Cap	$191M	$189M
Enterprise Value	$185M	$104M
Price	$2.48	$3.52
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	7.56x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.81x	1.15x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.50x	-1.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	-100.0%
Forward Rev Growth	325.8%	167.6%
Profitability
Gross Margin (TTM)	0.0%	88.7%
Operating Margin (TTM)	0.0%	87.4%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	99.4%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-99M	$-80M
FCF (TTM)	$-74M	$-69M
EPS (TTM)	-$0.87	-$0.96
ROE (TTM)	-9848.0%	-5389.0%
ROA (TTM)	-6897.0%	-4997.0%
ROIC (TTM)	-9848.0%	-5389.0%
Financial Health
Cash	$7M	$85M
Debt	$0	$0
Net Cash/Debt	$7M	$85M
Current Ratio (TTM)	7.90x	17.38x
Quick Ratio (TTM)	7.60x	17.16x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.01	0.99
52W Performance	-13.6%	65.3%
YTD Performance	53.1%	44.3%
% from 52W High	-46.1%	-35.9%
% from 52W Low	83.7%	88.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.23x
FCF Yield (TTM)	-38.6%	-36.6%
Earnings Yield (TTM)	-51.5%	-42.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-100.0
EV/GP/RG	N/A	N/A
Ticker research	View ELDN research	View WHWK research